NSEGeneral Updates1d ago · 17 Nov 2026, 10:27 pm

General Updates

Senores Pharmaceuticals Limited · SENORES

✦ AI Summary▲ PositiveRegulatory

Senores Pharmaceuticals Limited's subsidiary, Ratnatris Pharmaceuticals Private Limited, has received the PIC/S GMP certification from the State Service of Ukraine on Medicines and Drugs Control, expanding the company's pathway to pursue regulatory approvals in semi-regulated markets.

Analysis Scores

Earnings Impact5/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Senores Pharmaceuticals Limited is pleased to announce that the manufacturing facility of our subsidiary company, Ratnatris Pharmaceuticals Private Limited located at Mehsana, Gujarat has been awarded with the prestigious Pharmaceutical Inspection Co-operation Scheme ( PIC/S ) Good Manufacturing Practices ( GMP ) certification by the State Service of Ukraine on Medicines and Drugs Control ( SMDC )

Attachments (1)

📄

SENORES_17112026222647_intimation.pdf

pdf

Download →
View document text
Date: November 17, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Sub.: Regulation 30 Disclosure regarding issuance of Certificate of GMP Compliance by the State Service of Ukraine on Medicines and Drugs Control Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to announce that the manufacturing facility of our subsidiary company, Ratnatris Pharmaceuticals Private Limited located at Mehsana, Gujarat has been awarded with the prestigious Pharmaceutical Inspection Co-operation Scheme (“PIC/S”) Good Manufacturing Practices (“GMP”) certification by the State Service of Ukraine on Medicines and Drugs Control (“SMDC”). With this certification, the Company through it’s subsidiary now has an expanded pathway to pursue regulatory approvals across semi regulated market. The certificate of GMP compliance was issued by SMDC on November 16, 2026, which is received by the Company on November 17, 2026. You are requested to take the same on record. Thanking you. For Senores Pharmaceuticals Limited Shilpa Sharma Company Secretary and Compliance Officer ICSI Membership No.: A34516 Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263